5 years ago only a few ophthalmologists explored the subject of vitreolysis; today the subject has already sparked the interest of multiple university clinics in Germany. The treatments have now been introduced at the largest university clinic in the Netherlands, “Het Oogziekenhuis Rotterdam”. As you can see in the News
section, I have accepted invitations by specialist organizations such as NOG und ÖOG (Netherland’s and Austria’s Society of Ophthalmology) to hold lectures. DOC Nuremburg http://www.doc-nuernberg.de/
has approached me to organize a 90-minute course addressing the YAG laser vitreolysis topic. This is the official introduction of this subject to the largest congress for ophthalmological surgery in the German-speaking regions.
In retrospect, this is a wonderful development I have had the honour to support during the past years. We have already been able to able to help numerous patients. But we have yet to reach our goal. Many improvements are still pending, especially to benefit the patients we have not been able to help up to now. This includes new approaches, such as atropine treatment to reduce the awareness of floaters. The university clinic in Rostock is working on a therapy approach to increase the awareness threshold of obstructive floaters by means of behavioural therapy. Unfortunately the statutory healthcare system does not subsidize these endeavours to research further treatment options. Retrospectively this has also applied to other diseases. Treating cataracts with phacoemulsification was frowned upon initially in professional circles. Today it is one of the most frequently performed interventions worldwide.
My colleagues and I will continue to work on this type of development with great diligence.
Dr. med. Karl Brasse MRCOphth